O
Oliver S. Chow
Researcher at Cornell University
Publications - 31
Citations - 1705
Oliver S. Chow is an academic researcher from Cornell University. The author has contributed to research in topics: Medicine & Neoadjuvant therapy. The author has an hindex of 10, co-authored 23 publications receiving 1168 citations. Previous affiliations of Oliver S. Chow include University of Medicine and Dentistry of New Jersey & Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Julio Garcia-Aguilar,Oliver S. Chow,David D. Smith,Jorge E. Marcet,Peter A. Cataldo,Madhulika G. Varma,Anjali S. Kumar,Samuel Oommen,Theodore Coutsoftides,Steven R. Hunt,Michael J. Stamos,Charles A. Ternent,Daniel O. Herzig,Alessandro Fichera,Blase N. Polite,David W. Dietz,Sujata Patil,Karin Avila +17 more
TL;DR: Delivery of mFOLFOX6 after chemoradiation and before total mesorectal excision has the potential to increase the proportion of patients eligible for less invasive treatment strategies; this strategy is being tested in phase 3 clinical trials.
Journal ArticleDOI
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith,Paul Strombom,Oliver S. Chow,Campbell S.D. Roxburgh,Campbell S.D. Roxburgh,Patricio B. Lynn,Anne Eaton,Maria Widmar,Karuna Ganesh,Rona Yaeger,Andrea Cercek,Martin R. Weiser,Garrett M. Nash,Jose G. Guillem,Larissa K. Temple,Sree Bhavani Chalasani,James L. Fuqua,Iva Petkovska,Abraham J. Wu,Marsha Reyngold,Efsevia Vakiani,Jinru Shia,Neil H. Segal,James D. Smith,Christopher H. Crane,Marc J. Gollub,Mithat Gonen,Leonard B. Saltz,Julio Garcia-Aguilar,Philip B. Paty +29 more
TL;DR: A WW strategy for select rectal cancer patients who had a clinical complete response after neoadjuvant therapy resulted in excellent rectal preservation and pelvic tumor control; however, in the WW group, worse survival was noted along with a higher incidence of distant progression in patients with local reg growth vs those without local regrowth.
Journal ArticleDOI
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial
Julio Garcia-Aguilar,Lindsay A. Renfro,Oliver S. Chow,Qian Shi,Xiomara W. Carrero,Patricio B. Lynn,Charles R. Thomas,Emily Chan,Peter A. Cataldo,Jorge E. Marcet,David S. Medich,Craig S. Johnson,Samuel Oommen,Bruce G. Wolff,Alessio Pigazzi,Shane M McNevin,Roger K Pons,Ronald Bleday +17 more
TL;DR: The data suggest that nCRT followed by LE may be considered as an organ-preserving alternative in carefully selected patients with clinically-staged T2N0 tumours who refuse, or are not candidates for, transabdominal resection.
Journal ArticleDOI
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
J. Joshua Smith,Oliver S. Chow,Marc J. Gollub,Garrett M. Nash,Larissa K. Temple,Martin R. Weiser,Jose G. Guillem,Philip B. Paty,Karin Avila,Julio Garcia-Aguilar +9 more
TL;DR: This study compares 3-year disease-free survival (DFS) in an entire population of patients with LARC, including those with cCR and those with pCR, and is the first NOM trial utilizing a regression schema for response assessment in a prospective fashion.
Journal ArticleDOI
Immunonutrition: Role in Wound Healing and Tissue Regeneration.
Oliver S. Chow,Adrian Barbul +1 more
TL;DR: This work has shown a better understanding of the conditionally essential role of various nutrients such as arginine, which becomes essential in certain clinical situations such as for the trauma patient or patients at high risk for malnutrition.